Christy Fischer has never felt lost or sorry for herself during the 18 years since her diagnosis with stage IV lung cancer.

In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke ...

Globally, the prevalence of adolescents experiencing symptoms of anxiety and depression has been rising steeply in the past two decades,1 and diagnoses continue to increase.2 Symptoms of anxiety and ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...